RETRACTED: Mammalian STE20-Like Kinase 2 Promotes Lipopolysaccharides-Mediated Cardiomyocyte Inflammation and Apoptosis by Enhancing Mitochondrial Fission
A Retraction of the Original Research article
Mammalian STE20-like kinase 2 promotes lipopolysaccharides-mediated cardiomyocyte inflammation and apoptosis by enhancing mitochondrial fission
by Tian, Y., Song, H., Qin, W., Ding, Z., Zhang, Y., Shan, W., and Jin, D. (2020). Front. Physiol. 11:897. doi: 10.3389/fphys.2020.00897
The Publisher retracts the cited article.
Following publication, the publisher uncovered evidence that false identities were used in the peer-review process. The assignment of a fake reviewer was confirmed by an investigation, conducted in accordance with Frontiers’ policies and the Committee on Publication Ethics (COPE) guidelines.
The investigation also uncovered concerns about the presentation and validity of the data in the article that normally would have led to a rejection. When contacted, the authors failed to provide a data set that adequately supports the reported conclusions.
The authors do not agree to this retraction.
This retraction was approved by the Chief Editors of Frontiers in Physiology and the Chief Executive Editor of Frontiers.
Citation: Frontiers Editorial Office (2022) Retraction: Mammalian STE20-like kinase 2 promotes lipopolysaccharides-mediated cardiomyocyte inflammation and apoptosis by enhancing mitochondrial fission. Front. Physiol. 13:1006549. doi: 10.3389/fphys.2022.1006549
Received: 29 July 2022; Accepted: 02 August 2022;
Published: 04 August 2022.
Approved by:
John D. Imig, Medical College of Wisconsin, United StatesCopyright © 2022 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org